GlassScriptPhysician profile
Edwin Lionel Schmidt
NPI 1518935543
$2,387.85
in general payments reported to CMS, 2019-2025
12 companies · $706 in 2025
The $706 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.74 · 2022: $364 · 2023: $603 · 2024: $673 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,186.89 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Abbott Laboratories | $718.78 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Epic |
| Peerless Surgical INC. | $137.96 | 2024-2025 | |
| Dilon Technologies, INC. | $93.71 | 2025 | Hemoblast Bellows |
| Edwards Lifesciences Corporation | $67.30 | 2021-2025 | Sapien 3 Ultra Resilia |
| Kci USA, INC. | $44.71 | 2023 | Prevena, V.A.C.Instill |
| Cvrx, INC. | $27.75 | 2022-2025 | Barostim Neo System |
| Ethicon US, LLC | $27.47 | 2022-2025 | Prolene, Evarrest |
| Getinge USA Sales, LLC | $22.99 | 2025 | Vasoview Hemopro 2 |
| W. L. Gore & Associates, INC. | $21.71 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Solventum Corporation | $19.76 | 2025 | Prevena |
| Cardiva Medical, INC. | $18.82 | 2024 | Savvywire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.